Physician profile

Surendra K Jain

Cardiovascular Disease · Houston, TX

NPI 1326036195

$19,459.29

in general payments reported to CMS, 2019-2025

57 companies · $1,765 in 2025

The $1,765 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,264.97

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,551.57 2019-2025 General - Therapies, Ranger, Bodyguardian
Janssen Pharmaceuticals, INC $2,127.59 2019-2024 Xarelto
E.R. Squibb & Sons, L.L.C. $1,249.37 2019-2025 Eliquis, Camzyos
Abbott Laboratories $1,201.16 2019-2025 Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint, Cardiomems
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,167.04 2019-2025 Lifevest
Pfizer INC. $876.57 2019-2025
Astrazeneca Pharmaceuticals LP $822.70 2019-2025 Wainua, Farxiga, Lokelma
Actelion Pharmaceuticals US, INC. $817.33 2019-2025 Opsumit, Uptravi
Impulse Dynamics (USA) INC. $802.72 2021-2023 Optimizer
Novartis Pharmaceuticals Corporation $791.32 2019-2025
Amgen INC. $698.01 2019-2025 Repatha, Repatha
Endologix LLC $573.10 2020-2023
Medtronic, INC. $541.45 2021-2022
Novo Nordisk INC $528.67 2022-2025 Wegovy, Ozempic
Boehringer Ingelheim Pharmaceuticals, INC. $458.36 2019-2025 Jardiance
Show all 57 companies
CompanyGeneral paymentsYearsTop products
Penumbra, INC. $385.72 2020-2021
Medtronic Vascular, INC. $365.97 2019-2020
Esperion Therapeutics, INC. $338.44 2020-2025 Nexletol
Merck Sharp & Dohme LLC $306.87 2022-2025 Verquvo
Sanofi-Aventis U.S. LLC $291.26 2019-2022
Bayer Healthcare Pharmaceuticals INC. $277.74 2019-2025
Chiesi USA, INC. $275.90 2019-2024 Kengreal, Cleviprex
Amarin Pharma, INC. $229.97 2019-2022
Preventice Services, LLC $187.69 2019-2021
Heartflow, INC. $177.84 2021-2024 Ffrct
Lexicon Pharmaceuticals, INC. $164.17 2023-2024 Inpefa
Inari Medical, INC. $102.60 2021-2022
Cvrx, INC. $80.53 2021-2025 Barostim Neo System
Kiniksa Pharmaceuticals International, Plc $70.68 2024 Arcalyst
Angiodynamics, INC. $65.69 2019-2022
United Therapeutics Corporation $60.04 2023-2025 Tyvaso, Tyvaso
Abiomed $52.44 2025
Cardiva Medical, INC. $48.06 2022
Biotronik INC. $47.45 2021
Irhythm Technologies, INC. $47.06 2023-2024 Zio Xt Patch, Zio Monitor
Daiichi Sankyo INC. $46.50 2023 Injectafer
Shockwave Medical, INC $46.22 2021-2022
Alnylam Pharmaceuticals INC. $45.19 2020-2021
Tactile Systems Technology INC $43.74 2021-2022
Kiniksa Pharmaceuticals, LTD. $42.94 2022-2023 Arcalyst
Baxter Healthcare $42.12 2024 Hillrom - Carnation Ambulatory Monitor
Takeda Pharmaceuticals U.S.A., INC. $38.45 2025 Livtencity
Bridgebio Pharma, INC. $37.57 2025 Attruby
Cleerly, INC. $37.17 2024 Cleerly Ischemia, Cleerly Labs
Lilly USA, LLC $33.50 2025 Mounjaro, Zepbound
Avinger INC. $30.50 2020
Bardy Diagnostics, INC. $29.00 2022
Cardiovascular Systems INC. $26.88 2022
Surmodics, INC. $26.61 2022
Astellas Pharma US INC $24.87 2019
Regeneron Healthcare Solutions, INC. $24.39 2019
Lundbeck LLC $20.46 2020
Medicomp INC $19.70 2020
Agepha Pharma Fz LLC $16.81 2024 Lodoco
Arbor Pharmaceuticals, INC. $15.36 2020
Cashflow Solutions, LLC $14.45 2024 Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White
Kestra Medical Technology Services, INC. $13.78 2025 Assure Wcd

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Surendra K Jain

$19,459.29

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,765 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/195807/surendra-k-jain

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.